Head of Regeneron Cell Medicines
Core
Sets vision, strategy, and execution for Regeneron's cell medicines portfolio (ex vivo and in vivo CAR T programs) and technology platform, advancing transformative cell-based therapies from discovery to early clinical development.
Role type
Senior scientific executive (Head of Cell Medicines)
Builds
Ex vivo and in vivo CAR T therapies, enabling technologies for delivery (LNPs, viral vectors), and chemo-free conditioning platforms
Domain
Biopharmaceuticals / Cell and Gene Therapy / Immunology
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Cell engineering (CAR design, viral vectors), in vivo gene delivery, CMC considerations, regulatory pathway familiarity (FDA/EMA), portfolio management, resource planning, financial acumen, strategic vision, scientific rigor, talent development, cross-functional collaboration
Preferred skills
None explicitly stated as preferred
Technologies
LNPs, viral vectors, LVV, CAR T, antibody-based approaches (CPIs, bispecifics), ARMoR'ing strategies
Responsibilities
Define long-term scientific vision and portfolio strategy; prioritize programs using data-driven governance; lead matrixed teams to deliver milestones from target validation to IND and Phase I; build and mentor senior scientific leaders; partner with Research, Clinical, Regulatory, and Manufacturing functions; manage budgets and headcount planning; represent the site at executive forums and external conferences
Seniority
Executive, strategic leadership & mentorship
